Yüklüyor......
Early Triple Negative Breast Cancer: Conventional Treatment and Emerging Therapeutic Landscapes
Triple negative breast cancers (TNBCs) are characterized by worse prognosis, higher propensity to earlier metastases, and shorter survival after recurrence compared with other breast cancer subtypes. Anthracycline- and taxane-based chemotherapy is still the mainstay of treatment in early stages, alt...
Kaydedildi:
| Yayımlandı: | Cancers (Basel) |
|---|---|
| Asıl Yazarlar: | , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
MDPI
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7225917/ https://ncbi.nlm.nih.gov/pubmed/32235297 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12040819 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|